Siirry sisältöön
Ihmisen safenilaskimon endoteelisolut (HSVEC)
Kudos
Saphenous vein
Sairaus
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastaasikohde
Not applicable (normal, non-tumorigenic primary cell)
Synonyymit
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Asiakirjat

Ihmisen safenilaskimon endoteelisolut (HSVEC)

Primary cell · Tuotenumero 300699

Venous endothelium for bypass graft research

€1,220.00ilman veroja ja toimituskuluja

Räätälöinti / Suositukset

Valmistetaan tilauksesta
1

01Yleistä tietoa

Kuvaus

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Kudos
Saphenous vein
Sairaus
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastaasikohde
Not applicable (normal, non-tumorigenic primary cell)
Sovellukset
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Synonyymit
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Lahjoittaja

Luovuttajan ikä
Lot-specific (see CoA)
Etnisyys
Lot-specific (see CoA)

03Luokittelu

Organismi
Ihminen
Sukupuoli
Tonttikohtainen
Kasvuominaisuudet
Kiinnittynyt
GMO-status
GMO-vapaa
GMO-statuksen tiedot
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Bioturvallisuustaso
1

04Ominaisuudet

Morfologia
Cobblestone (endothelial)
Solutyyppi
Primary endothelial cells
Kasvaimia aiheuttava
No
Kaksinkertaistumisaika
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Käsittely ja viljely

Viljelyalusta
Endothelial Cell Growth Medium
Inkubaatioilma

37°C, 5% CO2, saturated humidity.

Ravintolisät
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Dissosiaatioreagenssi
Subculture reagents as recommended on the certificate of analysis
Pullon pinnoitus
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Soluviljely

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Jakosuhde
1 to 3
Kylvötiheys
More than 6,000 cells/cm²
Nesteen uusiminen
24 hours after seeding, then every 48 to 72 hours
Sulamisen jälkeinen palautuminen

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Sulatus ja viljely
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Laadunvalvonta ja kryosäilytys

Hedelmättömyys

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Jäädytysaine
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Säilytysolosuhteet

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Toimitusehdot

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Ilmentyminen ja alttius

Pinta-antigeenit
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Ilmentyvät reseptorit
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Tunnisteet

Lähdeviite
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI-verotunnus
9606
Cellosaurus
Not assigned